Genetically modified cell sheets in regenerative medicine and tissue engineering

Biomaterials. 2021 Aug:275:120908. doi: 10.1016/j.biomaterials.2021.120908. Epub 2021 May 24.

Abstract

Genetically modified cell sheet technology is emerging as a promising biomedical tool to deliver therapeutic genes for regenerative medicine and tissue engineering. Virus-based gene transfection and non-viral gene transfection have been used to fabricate genetically modified cell sheets. Preclinical and clinical studies have shown various beneficial effects of genetically modified cell sheets in the regeneration of bone, periodontal tissue, cartilage and nerves, as well as the amelioration of dental implant osseointegration, myocardial infarction, skeletal muscle ischemia and kidney injury. Furthermore, this technology provides a potential treatment option for various hereditary diseases. However, the method has several limitations, such as safety concerns and difficulties in controlling transgene expression. Therefore, recent studies explored efficient and safe gene transfection methods, prolonged and controllable transgene expression and their potential application in personalized and precision medicine. This review summarizes various types of genetically modified cell sheets, preparation procedures, therapeutic applications and possible improvements.

Keywords: Cell sheet; Gene modification; Regenerative medicine; Tissue engineering; Transfection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone and Bones
  • Cartilage
  • Osseointegration
  • Regenerative Medicine*
  • Tissue Engineering*